Aprecia Pharmaceuticals
We partner with pharmaceutical companies to bring innovative, commercial scale 3DP manufacturing capabilities to their existing product portfolios and research pipelines.
APRECIA is The 3DP Pharmaceutical Company. Our proprietary, advanced fast-melt dose form innovation, ZipDose, is the first and only 3DP technology platform used in an FDA approved product. We partner with pharmaceutical companies to bring innovative, commercial scale 3DP manufacturing capabilities to their existing product portfolios and research pipelines. Advanced fast melt, high drug load, modified release, combination drugs are just a few of the possibilities our team can explore with you at AAPS PharmSci360.
Aprecia Pharmaceuticals
10901 Kenwood Road
Blue Ash, OH 45242
513.984.5000
contact@aprecia.com
AAPS Booth Number: 2143
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
